However, our study demonstrated that vitexin protected HUVECsfrom HG-induced endothelial dysfunction and inflammation via the suppressionof the NF-κB signaling pathway, suggesting that vitexin mightserve as a potential drug for vascular complications of diabetes. Here, NFKB1 is linked to endothelial dysfunction.